BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24718277)

  • 1. PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.
    Lee SH; Moon SJ; Park MJ; Kim EK; Moon YM; Cho ML
    Immunol Lett; 2014 Jul; 160(1):79-88. PubMed ID: 24718277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein inhibitor of activated STAT3 reduces peripheral arthritis and gut inflammation and regulates the Th17/Treg cell imbalance via STAT3 signaling in a mouse model of spondyloarthritis.
    Min HK; Choi J; Lee SY; Seo HB; Jung K; Na HS; Ryu JG; Kwok SK; Cho ML; Park SH
    J Transl Med; 2019 Jan; 17(1):18. PubMed ID: 30630513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation.
    Park MJ; Lee SH; Lee SH; Kim EK; Lee EJ; Moon YM; La Cho M
    J Transl Med; 2016 Jul; 14(1):206. PubMed ID: 27391226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking activator protein 1 activity in donor cells reduces severity of acute graft-versus-host disease through reciprocal regulation of IL-17-producing T cells/regulatory T cells.
    Park MJ; Moon SJ; Lee SH; Kim EK; Yang EJ; Min JK; Park SH; Kim HY; Yang CW; Cho ML
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1112-20. PubMed ID: 24813170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cucurbitacin E ameliorates acute graft-versus-host disease by modulating Th17 cell subsets and inhibiting STAT3 activation.
    Kim SY; Park MJ; Kwon JE; Jung KA; Jhun JY; Lee SY; Seo HB; Ryu JY; Beak JA; Choi JY; Cho ML
    Immunol Lett; 2018 Nov; 203():62-69. PubMed ID: 30240636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-22 promoted CD3+ T cell infiltration by IL-22R induced STAT3 phosphorylation in murine acute graft versus host disease target organs after allogeneic bone marrow transplantation.
    Zhao K; Ruan S; Tian Y; Zhao D; Chen C; Pan B; Yan Z; Yin L; Zhu S; Xu K
    Int Immunopharmacol; 2016 Oct; 39():383-388. PubMed ID: 27551984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.
    Wu Y; Bastian D; Schutt S; Nguyen H; Fu J; Heinrichs J; Xia C; Yu XZ
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1195-204. PubMed ID: 25846718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs.
    Park MJ; Lee SY; Moon SJ; Son HJ; Lee SH; Kim EK; Byun JK; Shin DY; Park SH; Yang CW; Cho ML
    Transl Res; 2016 Jul; 173():115-130. PubMed ID: 27126953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 21 blockade modulates activated T- and B-cell homeostasis via B-cell activating factor pathway-mediated inhibition in a murine model of acute graft-versus-host disease.
    Lim JY; Park MJ; Im KI; Kim N; Park HS; Lee SH; Kim EK; Nam YS; Lee ES; Cho ML; Cho SG
    Exp Hematol; 2015 Jan; 43(1):23-31.e1-2. PubMed ID: 25246268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of HMGB1 in regulation of STAT3 expression in CD4(+) T cells from patients with aGVHD after allogeneic hematopoietic stem cell transplantation.
    Xu YJ; Li L; Chen Y; Fu B; Wu DS; Li XL; Zhao XL; Chen FP
    Clin Immunol; 2015 Dec; 161(2):278-83. PubMed ID: 26327693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat acute GvHD is Th1 driven and characterized by predominant donor CD4
    Boieri M; Shah P; Jalapothu D; Zaitseva O; Walter L; Rolstad B; Naper C; Dressel R; Inngjerdingen M
    Exp Hematol; 2017 Jun; 50():33-45.e3. PubMed ID: 28238806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response.
    Betts BC; Sagatys EM; Veerapathran A; Lloyd MC; Beato F; Lawrence HR; Yue B; Kim J; Sebti SM; Anasetti C; Pidala J
    J Leukoc Biol; 2015 Apr; 97(4):807-19. PubMed ID: 25663681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model.
    Radojcic V; Pletneva MA; Yen HR; Ivcevic S; Panoskaltsis-Mortari A; Gilliam AC; Drake CG; Blazar BR; Luznik L
    J Immunol; 2010 Jan; 184(2):764-74. PubMed ID: 19995899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
    Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
    Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SIRT1 deficiency in CD4+T cells induces acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Zhang Y; Yang J; Zhang G; Peng J; Chen X; Chen F; Xu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):697-703. PubMed ID: 30124203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of interleukin-18 receptor on T lymphocytes in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Fujimori Y; Yoshimoto T; Matsui K; Tsutsui H; Okamoto T; Kashiwamura S; Hada T; Okamura H; Kakishita E; Hara H; Nakanishi K
    J Interferon Cytokine Res; 2002 Jul; 22(7):751-4. PubMed ID: 12184912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells.
    Riegel C; Boeld TJ; Doser K; Huber E; Hoffmann P; Edinger M
    Leukemia; 2020 Mar; 34(3):895-908. PubMed ID: 31719679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.